Information  X 
Enter a valid email address

Summit Corporation PLC (SUMM)

  Print      Mail a friend

Friday 20 April, 2012

Summit Corporation PLC

Summit Corporation PLC : Result of General Meeting

Summit Corporation PLC : Result of General Meeting

Summit Corporation plc
('Summit' or 'the Company')

RESULT OF GENERAL MEETING

Oxford, UK, 20 April 2012, Summit (AIM: SUMM), a UK drug discovery company, announces that at a General Meeting of the Company held earlier today, the resolutions, as set out in the Notice of General Meeting annexed to the circular to shareholders dated 4 April 2012, were duly passed, thereby enabling the proposed fundraising announced on 4 April 2012 to proceed.

The details of the votes cast will be available shortly on Summit's website (www.summitplc.com).

Glyn Edwards, Chief Executive Officer of Summit commented: "I would like to thank shareholders for their commitment to Summit and am appreciative of the valuable feedback provided on the fundraising.  We now look forward to concentrating on advancing our three key drug programmes to add value to these assets and support the future growth and development of your company."

- END -

For more information, please contact:

Summit
Glyn Edwards / Richard Pye
Tel: +44 (0)1235 443 939
Singer Capital Markets
(Nominated Adviser and Joint broker)
Shaun Dobson / Claes Spång


Tel: +44 (0)203 205 7500
Hybridan LLP
(Joint broker)
Claire Louise Noyce / Deepak Reddy


Tel: +44 (0)207 947 4350
Peckwater PR
(Financial public relations)
Tarquin Edwards

Tel: +44 (0)7879 458 364
tarquin.edwards@peckwaterpr.co.uk

Notes to Editors

About Summit
Summit is an Oxford, UK based drug discovery Company with an innovative Seglin(TM) technology platform for the discovery of new medicines and a portfolio of drug programme assets.  Summit's programme portfolio consists of a number of drug programmes targeting high-value areas of unmet medical need including Duchenne Muscular Dystrophy and C. difficile infection.  Summit is listed on the AIM market of the London Stock Exchange and trades under the ticker symbol SUMM.  Further information is available at www.summitplc.com.

Forward Looking Statements
This document contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "anticipates", "intends", "plans", "seeks", "believes", "estimates", "expects" and similar references to future periods, or by the inclusion of forecasts or projections. Forward-looking statements are based on the Company's current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward-looking statements. The Company cautions you therefore that you should not rely on any of these forward-looking statements as statements of historical fact or as guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements and regional, national, global political, economic, business, competitive, market and regulatory conditions.




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Summit Corporation PLC via Thomson Reuters ONE

HUG#1604514